Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?

Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?

Bibliographic Details
Main Authors:	Eduard Shantsila, Gregory Y.H. Lip
Format:	Article
Language:	English
Published:	Elsevier 2016-02-01
Series:	EBioMedicine
Subjects:	Heart failure Heart failure with preserved ejection fraction Endothelial progenitor cells Microparticles
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396416300214

Similar Items

Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT
by: Eduard Shantsila, et al.
Published: (2020-07-01)

Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction
by: Alexander E. Berezin, et al.
Published: (2016-02-01)

Heart failure with preserved ejection fraction – onset
by: Branimir Kanazirev
Published: (2021-07-01)

Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis
by: Chao Ma, et al.

Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension
by: Tetsuro Tsujimoto, et al.
Published: (2020-12-01)

Association of ambient temperature and acute heart failure with preserved and reduced ejection fraction
by: Takahiro Jimba, et al.
Published: (2022-10-01)

Circulating Endothelial Cells, Endothelial Progenitor Cells, and Endothelial Microparticles in Cancer
by: P.K.Y. Goon, et al.
Published: (2006-02-01)

Heart failure with preserved ejection fraction (HFpEF): Implications for the anesthesiologists
by: Ajmer Singh, et al.
Published: (2018-01-01)

Heart failure with preserved ejection fraction – new elements of evidence in the field of pathophysiology and new treatment options
by: Branimir Kanazirev
Published: (2021-07-01)

Heart failure with preserved ejection fraction: insights from recent clinical researches
by: Mi-Na Kim, et al.
Published: (2020-05-01)

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction
by: Chiara Borrelli, et al.
Published: (2019-09-01)

Cell Therapy for Heart Failure With Preserved Ejection Fraction∗
by: Barry A. Borlaug, MD, et al.
Published: (2016-01-01)

Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives
by: O. V. Tsygankova, et al.
Published: (2021-05-01)

Development and Challenges of Pre-Heart Failure with Preserved Ejection Fraction
by: Guoju Dong
Published: (2023-09-01)

The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction
by: Jerremy Weerts, et al.
Published: (2022-02-01)

Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction
by: Xin He, et al.
Published: (2021-08-01)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
by: Tin‐Kwang Lin, et al.
Published: (2019-06-01)

Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure
by: John Gierula, et al.
Published: (2022-10-01)

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial
by: Djawid Hashemi, et al.
Published: (2020-06-01)

Risk factors and prediction models for incident heart failure with reduced and preserved ejection fraction
by: Liam Gaziano, et al.
Published: (2021-12-01)

Dynamics of Vascular Stiffness and Endothelial Function in Combination Therapy of Heart Failure with Preserved Ejection Fraction
by: Z. M. Akhilgova, et al.
Published: (2020-07-01)

Heart failure with preserved ejection fraction—Out with the old and out with the new?
by: Luis Tolento Cortes, et al.
Published: (2022-07-01)

Diving Into the Diagnostic Score Algorithms of Heart Failure With Preserved Ejection Fraction
by: Dmitry Abramov, et al.
Published: (2021-06-01)

Heart Failure in Patients with Preserved Ejection Fraction: Questions Concerning Clinical Progression
by: George E. Louridas, et al.
Published: (2016-09-01)

Diagnostic and prognostic implications of heart failure with preserved ejection fraction scoring systems
by: Vibhu Parcha, et al.
Published: (2021-06-01)

Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population
by: Yook Chin Chia, et al.
Published: (2021-06-01)

Association of Body-Weight Fluctuation With Outcomes in Heart Failure With Preserved Ejection Fraction
by: Yi Li, et al.
Published: (2021-06-01)

Nutrient Intake and Exercise Capacity in Heart Failure With Preserved Ejection Fraction
by: Scott L. Hummel, MD, MS, et al.
Published: (2017-10-01)

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON‐HF trial
by: Lars H. Lund, et al.
Published: (2022-02-01)

Do we need a definition of acute heart failure with preserved ejection fraction?
by: Agnieszka Kapłon-Cieślicka, et al.
Published: (2021-01-01)

Understanding How Heart Metabolic Derangement Shows Differential Stage Specificity for Heart Failure with Preserved and Reduced Ejection Fraction
by: Federico Ferro, et al.
Published: (2022-07-01)

Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction
by: Francesca Graziani, et al.
Published: (2021-04-01)

Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction
by: Martin Bahls, et al.
Published: (2019-04-01)

Effect of combination antihypertensive therapy, including renin-angiotensin-aldosterone system inhibitors, on oxidative stress and arterial remodeling in hypertensive patients with heart failure with preserved ejection fraction
by: Z. M. Akhilgova, et al.
Published: (2021-06-01)

Common Heart Failure With Preserved Ejection Fraction Animal Models Yield Disparate Myofibril Mechanics
by: Axel J. Fenwick, et al.
Published: (2024-01-01)

Prevalence and prognosis of frailty in older patients with stage B heart failure with preserved ejection fraction
by: Chen Meng, et al.
Published: (2023-04-01)

Impact of plasma xanthine oxidoreductase activity in patients with heart failure with preserved ejection fraction
by: Ken Watanabe, et al.
Published: (2020-08-01)

Predictive Role of Diastolic Echocardiographic Findings in the Outcome of Heart Failure with Preserved Ejection Fraction
by: Farveh Vakilian, et al.
Published: (2016-01-01)

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
by: Kaiyuan Zhu, et al.
Published: (2021-07-01)

Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction
by: Adam K. McDiarmid, et al.
Published: (2020-01-01)